Related Experiment Video

Updated: Oct 12, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.3K

Antithrombotic Treatment of Stable Coronary Artery Disease

Yi-Heng Li1, I-Chang Hsieh2, Kwo-Chang Ueng3

  • 1National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan.

Acta Cardiologica Sinica
|November 23, 2021
PubMed

Insights

New antithrombotic strategies are needed for coronary artery disease (CAD) patients. Dual pathway inhibition combining antiplatelet and anticoagulant therapy shows promise, offering a new treatment option beyond current therapies.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Coronary artery disease (CAD) remains a leading cause of mortality.
  • Current secondary prevention therapies for CAD leave a significant residual risk of recurrent cardiovascular events.
  • There is a critical need for novel therapeutic strategies in CAD management.

Purpose of the Study:

  • To review unmet needs in current antithrombotic agents for CAD.
  • To summarize clinical trial data on dual antiplatelet therapy in stable CAD.
  • To evaluate the potential of dual pathway inhibition as a new treatment option for CAD.

Main Methods:

  • Literature review of current antithrombotic therapies for CAD.
  • Analysis of clinical trial results for dual antiplatelet therapy.
  • Examination of data on dual pathway inhibition strategies (antiplatelet and anticoagulant therapy).
  • Development of a treatment algorithm based on evidence and expert opinion.

Main Results:

  • Current antithrombotic agents have limitations and unmet needs in CAD.
  • Dual antiplatelet therapy has been studied in stable CAD with varying outcomes.
  • Dual pathway inhibition demonstrates potential benefits in recent studies for CAD treatment.

Conclusions:

  • Novel antithrombotic strategies are essential for improving outcomes in CAD.
  • Dual pathway inhibition represents a promising new therapeutic avenue for CAD.
  • A structured treatment algorithm can guide the selection of antithrombotic regimens in CAD.

Keywords:
AntithromboticsCoronary artery diseaseDual antiplatelet therapyDual pathway inhibition

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

83.9K
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

25.7K

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
63
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
45
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
48
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
63
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
390
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
52